Byotrol brings new Non Executive Director on board

18^th Dec 2007

Byotrol plc, the antimicrobial technology company has appointed Adrian Smith as its Non Executive Director bringing with him a wealth of experience in brand management, marketing and a number of senior management positions with global organisations.

Adrian joined the board of Byotrol plc in September 2007, and is currently the Chief Executive of The Woolton Group LLC. He also serves as a non executive director of Tutogen Medical Inc and Gaming VC S.A. where he is the board's non executive chairman.

With an extensive career which began in 1966, Adrian's first role was in sales and brand management with Procter & Gamble in the UK. From there he joined Ecolab Inc. in 1979 as Vice President for European Consumer Marketing. With Ecolab he relocated to the USA in 1981, holding senior management positions with global responsibility until 1990.

Since working with Ecolab, Adrian has worked as a managing partner for Arthur Andersen, Grant Thornton and Deloitte Touche Tohmatsu. Adrian is also a visiting lecturer at the University of Furtwangen in Germany and serves on the Board of The Education Foundation, a non profit organisation in Florida. Now living in Vero Beach, Florida and London, England, Adrian is married with four children and four grandchildren.

Commenting on his appointment, Adrian Smith said: "I am delighted to join the board of Byotrol. I intend to use my previous experience in brand management and marketing to contribute to the strategic development of the company. Byotrol's technology is a real success story and there is a wealth of opportunities for the company across a range of different markets. This is an exciting time for the company's development and I am pleased to be involved."

Wesley Devoto OBE, Byotrol's Non Executive Chairman added: "We are really pleased to welcome Adrian to the board of Byotrol plc and are confident that he will be a real asset to the company.

Our strategy to appoint a new Non Executive Director ensures that we have a key senior figure with a wealth of industry experience that can bring knowledge and expertise to our business."

Byotrol is a UK based company that has developed and patented a new antimicrobial technology.  The core proposition of the Byotrol Technology is safety, ease of use and delivery of a complete antimicrobial solution. The technology is available for commercial application within markets whereby microbial control and elimination of such hazards and threats is paramount, and as such Byotrol has established a product range for application within the healthcare, food & drink and technical & commercial industries.